Brincidofovir
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 268 publications
Mpox therapeutics in the post-STOMP/PALM era.
Journal: Current opinion in HIV and AIDS
Published: January 06, 2026
Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells.
Journal: The Journal of clinical investigation
Published: November 25, 2025
Maternal-Fetal Implications of Mpox Infection: Current Evidence.
Journal: Journal of clinical medicine
Published: November 22, 2025
Lipid-Optimized Sulfone-Bridged Cidofovir Prodrugs as Potent Antivirals Against Orthopoxviruses.
Journal: Journal of medicinal chemistry
Published: November 19, 2025
Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases.
Journal: JAAD case reports
Published: November 14, 2025
Investigational treatments for cytomegalovirus infection in phase I and II study.
Journal: Expert opinion on investigational drugs
Published: October 21, 2025
Re-emergence and clinical management of monkeypox: insights into viral biology, therapeutics, and vaccination.
Journal: Molecular biology reports
Published: August 13, 2025
Mpox: disease manifestations and therapeutic development.
Journal: Journal of virology
Published: August 11, 2025
Small molecule direct-acting antivirals for treatment of mpox.
Journal: Antiviral research
Published: August 11, 2025
Brincidofovir in the Era of Mpox.
Journal: Expert review of anti-infective therapy
Published: July 13, 2025
Last Updated: 02/24/2026